The expression of fragile histidine triad in primary hepatocellular carcinoma
- VernacularTitle:FHIT基因蛋白的表达与肝癌的临床关系
- Author:
Ronghua XU
;
Jilin YI
- Publication Type:Journal Article
- Keywords:
fragile histidine triad gene;
hepatocellular carcinoma;
immunohistochemistry
- From:
Journal of Clinical Surgery
2004;0(07):-
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the clinical significance of the expression of fragile histidine triad (FHIT) protein in primary hepatocellular carcinoma (HCC).Methods Immunohistochemical (S-P) method was used to detect the expression of FHIT in the 46 patients with HCC and 10 normal controls.Results In the patients with HCC,the expression rate of FHIT in the tumor tissue was 56.52%,significantly lowerthan that in adjacent non-tumor tissue and normal tissue.The absence of FHIT protein was correlated neither with the size,tumor capsule,serum AFP level nor with chronic hepatitis B virus infection and cirrhosis of liver.There was significant relationship between the expression of FHIT and differentiation and thrombus in the portal vein.Conclusion The loss of FHIT gene protein is a frequent event in HCC.Furthermore,the loss is closoly related to tumor prognosis prognosis and FHIT loss.
